Biopharmaceutical Companies & Market Analysis

The worldwide pharmaceutical industry was justified regardless of an expected $1 trillion in 2014. In 2013, worldwide pharmaceutical markets produced incomes of $980.1 billion. That year, North America (the US and Canada) contributed 41% of offers, while Europe contributed 27.4%. 

The medication fabricating class, the major traded on an open market organizations incorporate Johnson and Johnson, Novartis AG (NVS), Pfizer Inc. (PFE), Merck, Sanofi, and GlaxoSmithKline.

  • Latest Developments In Biopharma Market Trends
  • Novel Approaches In Biopharmaceuticals
  • Clinical Pharmacology And Therapeutics
  • Biopharmaceutical Manufacturing Process Development
  • Commercialization & Marketing

Related Conference of Biopharmaceutical Companies & Market Analysis

September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Biopharmaceutical Companies & Market Analysis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in